Welcome14th Annual International Meeting of the Institute of Human Virology

JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/01.qai.0000429199.30440.e5
Program Information and Acknowledgements

    at the University of Maryland School of Medicine

    By: Dr. Robert C. Gallo, M.D.

    Co-Founder & Director, IHV

    Dear Colleagues and Friends,

    This year’s meeting will be held in Baltimore Sunday, October 14 – Wednesday, October 17. Leading virologists will descend upon the City to share and examine innovative scientific breakthroughs in HIV/AIDS biology - from basic science to clinical research. We will also hear from distinguished experts on HIV-associated diseases and malignancies. Additionally, we will again include our popular Special Symposium on Africa to review and address the development of clinical research capacity on the continent and issues related to health care delivery in resource-poor countries.

    Our meeting returns to the beautiful Marriott Waterfront Hotel located in the Harbor East community of Baltimore City. This premiere venue not only has spectacular views of Baltimore’s renowned Inner Harbor area, but also provides easy access to the city’s finest shopping and restaurants.

    In addition to our scientific sessions, we look forward to this year’s IHV Awards Gala on the evening of Tuesday, October 16. IHV will honor Thomas Waldmann, M.D. as our Lifetime Achievement Award recipient for Scientific Contributions. Tom is Head of the Cytokine Immunology and Immunotherapy Section at NIH’s National Cancer Institute, where he has now served for more than five decades. Tom has made many key contributions to the field of immunology – both in basic and clinical research and especially to our knowledge of normal and abnormal T-cell biology. His work has had a major impact on the researchers at IHV, and truly all over the world. This also includes his pioneering and seminal contributions to the Human T-lymphotropic virus Type I (HTLV-1).

    The 2012 IHV Lifetime Achievement Award in Public Service will be presented to Yi Zeng, Ph.D., Dean of the College of Life Science and Bioengineering at Beijing University of Technology. Professor Zeng has been an illustrious virologist and cancer researcher for many decades in China, a leader of several Chinese Institutions and an Academician of the Chinese Academy of Sciences. Of all his contributions, he is best known for his discovery of the first example of co-carcinogenesis in humans through the combination of infection with Epstein-Barr virus (EBV) and chemical products from ingestion of particular foods derived from certain plants in Southern China.

    IHV is also pleased to present a Lifetime Achievement Award for Excellence in Medical Education, Clinical Care, and Clinical Research to John Bartlett, M.D., Professor of Medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine. He served as Chief of the Infectious Diseases Division at the School for 26 years, stepping down in July of 2006. Dr. Bartlett has established himself as the leading infectious disease expert in the world.

    We look forward to you joining us in Baltimore to explore the most recent and important developments in HIV/AIDS research and to honor each of the Award recipients for their work in advancing human health.


    Robert C. Gallo, MD

    Director and Professor

    Institute of Human Virology

    Back to Top | Article Outline

    Mission Statement

    The Institute of Human Virology (IHV) is a world-class center of excellence focusing on chronic viral diseases and virally linked cancers. IHV is dedicated to biomedical research leading to improved treatment and prevention of these diseases.

    Our unique structure connects cohesive, multidisciplinary research and clinical programs so that new treatments are streamlined from discovery to patients. IHV is forging local and international programs for research and treatment of human disease.

    Robert C. Gallo


    Co-Director, Division of Basic Science and Vaccine Research

    William A. Blattner

    Associate Director

    Director, Division of Epidemiology and Prevention

    Robert R. Redfield

    Associate Director

    Director, Division of Clinical Care and Research

    C. David Pauza

    Associate Director

    George Lewis

    Co-Director, Division of Basic Science and Vaccine Research

    Joseph L. Bryant

    Director, Division of Animal Models

    Dave Wilkins

    Chief Operating Officer

    Back to Top | Article Outline

    Board of Advisors

    Terry Lierman (Chair)

    Partner, Summit Global Ventures

    Rockville, MD

    Robert Charrow

    Greenberg-Traurig, LLP

    Washington, DC

    Janet Langhart Cohen

    Langhart Communications

    Chevy Chase, MD

    Barbara J. Culliton

    Science Journalist and

    Policy Consultant

    Washington, DC

    Elijah Cummings

    US House of Representatives

    Baltimore, MD

    Mr. John Evans

    Evans Telecommunications

    Ft. Lauderdale, FL

    Arthur J. Gajarsa

    United States Court of Appeals

    for the Federal Circuit (Ret)

    Washington, DC

    Mr. Robert Gray

    Chairman, Gray and Company II

    Miami Beach, FL

    Stewart Greenebaum

    Greenebaum & Rose

    Associates, Inc.

    Baltimore, MD

    Ernest F. Hollings

    Medical University of

    South Carolina

    Charleston, SC

    Harry Huge

    Charleston, SC

    Mark Kaplan

    University of Michigan

    Medical Center

    Ann Arbor, MI

    Sheilah A. Kast

    WYPR Radio

    College Park, MD

    Honorable Nancy Kopp

    State Treasurer

    Maryland State Government

    Annapolis, MD

    Reinhard Kurth

    Ernst Schering Foundation

    Berlin, Germany

    Mr. Thomas Lynch

    Amarin Pharmaceutical, Ltd.

    Dublin, Ireland

    HRH Princess

    Chulabhorn Mahidol

    Mahidol University

    Bangkok, Thailand

    Sharon Malone

    Fox Hall Ob-Gyn

    Washington, DC

    Timothy Moynahan

    Moynahan & Minella, LLC

    Waterbury, CT

    Franco Nuschese

    Georgetown Entertainment Group

    Washington, DC

    Joseph Pagano

    University of North Carolina

    at Chapel Hill

    Chapel Hill, NC

    Peter Palese

    Mount Sinai School of Medicine

    New York, NY

    Jeffrey Trammell

    Trammel and Company

    Washington, DC

    Lenny Wilkens

    National Basketball Association Hall

    of Fame Coach and Player

    Medina, WA

    Back to Top | Article Outline

    Ex-Officio Members

    Robert C. Gallo


    Institute of Human Virology

    William E. Kirwan


    University System of Maryland

    E. Albert Reece


    University of Maryland

    School of Medicine

    Back to Top | Article Outline

    Scientific Advisory Board

    Joseph Pagano, MD (Chair)


    Scientific Advisory Board

    University of North Carolina

    Chapel Hill School of Medicine

    Edward A. Berger, PhD

    National Institutes of Health

    Farley R. Cleghorn, MD, MPH

    Constella Futures

    Myron S. Cohen, MD

    University of North Carolina

    Chapel Hill

    Max Essex, DVM, PhD

    Harvard AIDS Institute

    Warner Greene, MD, PhD

    Gladstone Institute of Virology and Immunology

    William Hall, MD

    University College Dublin

    Mark Kaplan, MD, FACP

    University of Michigan

    Medical Center

    Michel Klein, PhD

    Canadian Network for Vaccines

    and Immunotherapeutics

    Erling C. J. Norrby, MD, PhD

    The Royal Swedish Academy

    of Sciences

    William Paul, MD

    National Institutes of Health

    Mario Stevenson, PhD

    University of Miami

    Sten Vermund, MD, PhD

    University of Alabama

    Back to Top | Article Outline

    Organizing Committees

    The Institute of Human Virology at the University of Maryland School of Medicine is grateful for the assistance provided by our Organizing Committees.

    Back to Top | Article Outline

    International Organizing Committee

    William Hall, MD, PhD

    Centre for Research in Infectious Diseases

    Dublin, Ireland

    Robert Siliciano, MD, PhD

    Johns Hopkins University

    School of Medicine

    Baltimore, MD

    Arsene Burny, PhD

    University of Brussels

    Brussels, Belgium

    John Moore, PhD

    Weill Medical College of Cornell University

    New York, New York

    Alain Lafeuillade, MD

    Department of Infectious Diseases

    Toulon, France

    David Montefiore, PhD

    Duke University Medical Center

    Durham, North Carolina

    James Mullins, PhD

    University of Washington

    Seattle, Washington

    Anna Linda Zignego

    University of Florence

    Firenze, Italy

    Paolo Rossi, MD, PhD

    Ospedale Bambino Gesu

    Rome, Italy

    Guido Poli, MD

    San Raffaele Scientific Institute

    Milano, Italy

    Ligia Peralta, MD, FAAP, FSAM

    University of Maryland

    Medical System

    Baltimore, MD

    Kevin Cullen, MD

    Director, Marlene and Stewart

    Greenebaum Cancer Center

    University of Maryland

    Medical School

    Baltimore, MD

    Back to Top | Article Outline

    Local Organizing Committee

    C. David Pauza

    Institute of Human Virology

    Baltimore, MD

    Lai-Xi Wang

    Institute of Human Virology

    Baltimore, MD

    Alfredo Garzino-Demo

    Institute of Human Virology

    Baltimore, MD

    Fabio Romerio

    Institute of Human Virology

    Baltimore, MD

    Eric Sundberg

    Institute of Human Virology

    Baltimore, MD

    Alash’le Abimiku

    Institute of Human Virology

    Baltimore, MD

    Ligia Peralta

    University of Maryland

    School of Medicine

    Baltimore, MD

    Back to Top | Article Outline

    Communications and Press Policy

    To enhance the exchange of information and communication among attendees of the Institute of Human Virology Annual International Meeting, the following must be adhered to by all participants:

    – All comments at sessions are off-the-record and are not for attribution.

    – No coverage, reporting or publication of scientific data or presentations at the Institute of Human Virology Annual Meeting is permitted without the written consent of the presenter(s) and Nora Grannell (info below). This rule applies to all forms of media, including blogging.

    One-on-one interviews with scientists and media may be arranged by contacting Nora Grannell, Director of Public Relations and Marketing, Institute of Human Virology, (410) 706-1954 or .

    Back to Top | Article Outline

    Special Acknowledgements

    The Institute of Human Virology at the University of Maryland would like to thank the following organizations. Without their continued and generous support this meeting would not be possible.

    Special Benefactor

    Gilead Sciences

    Profectus Biosciences


    Division of AIDS, NIH

    National Institute of Allergy and Infectious Diseases

    Office of AIDS Research


    U.S. Military HIV Research Program


    Global HIV Vaccine Enterprise




    The Greenebaum Cancer Center

    Back to Top | Article Outline

    2012 IHV Lifetime Achievement Award for Scientific Contributions

    Thomas A. Waldmann, M.D.

    Thomas A. Waldmann, M.D. received his M.D. from Harvard Medical School. He joined the NCI in 1956, and has been Chief of Metabolism Branch since 1973. Over his 56-year career he defined the IL-2 receptor subunits, IL-2R beta and IL-2R alpha using the first-ever reported anti-cytokine receptor monoclonal antibody (anti-Tac, daclizumab, Zenapax). These studies culminated in the definition of the IL-2 receptor as an exceptionally valuable target for monoclonal antibody mediated therapy of leukemia, lymphoma, and multiple sclerosis. He co-discovered IL-15, elucidated its role in persistence of NK and CD8 memory T-cells and completed a first in-human trial of IL-15 in patients with metastatic malignancy. He introduced blockade of the IL-15/IL-15 receptor and its Jak/STAT signaling pathway for leukemias and autoimmune diseases where gamma-c cytokines including IL-15 play a pathogenic role.

    Figure. No caption a...

    His honors include: the Ehrlich Medal, Abbott Laboratories Prize, Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research, Milken Family Medical Foundation Distinguished Basic Scientist Award, Artois-Baillet Latour Health Prize, AAI-Dana Foundation Award in Human Immunology Research and election to the National Academy of Sciences, American Academy of Arts and Sciences, Institute of Medicine of the National Academy of Sciences and Royal Society of the Medical Sciences (UK).

    Back to Top | Article Outline

    2012 IHV Lifetime Achievement Award for Public Service

    Yi Zeng, Ph.D.

    Professor Yi Zeng, who graduated from Shanghai First Medical College in 1952, is a member of Chinese Academy of Sciences, foreign member of France National Academy of Medical Sciences and Russian Academy of Medical Sciences. He is now Chief of the Department of Oncogenic Viruses and HIV/AIDS of the Institute for Viral Disease Control and Prevention, China CDC, and Dean of the College of Life Science and Bioengineering in Beijing University of Technology. He was formally director of the Institute of Virology, the president of Chinese Association of Preventive Medicine, WHO Expert Advisory Panel on Cancer, and a member of Executive Board of International Union of Microbiology. Yi Zeng is the first scientist to study viral oncology and HIV in China and began his work in this field in 1961. Since 1973 his main focus has been on the relationship between EB virus and nasopharyngeal carcinoma, HPV and esophageal cancer, HBV and liver cancer, HTLV-1 and adult T cell leukaemia, HHV-8 and kaposi sarcoma. In 1984 he began his work on HIV and AIDS.

    Figure. No caption a...

    Professor Zeng has published more than 500 papers and 6 books in Chinese and English and has been honored with more than 20 awards from the Ministry of Science and Technology of China and Ministry of Health of China. He has also been honored with awards for HIV/AIDS Control and Prevention from British Barry and Martin’s Trust.

    Back to Top | Article Outline

    2012 IHV Lifetime Achievement Award for Excellence in Medical Education, Clinical Care and Clinical Research

    John G. Bartlett, M.D.

    John G. Bartlett, M.D., is a Professor of Medicine in the Division of The Johns Hopkins University School of Medicine, Baltimore, Maryland. He served as Chief of the Infectious Disease Division at the School for 26 years, stepping down in July of 2006. Dr. Bartlett received his undergraduate degree at Dartmouth College, Hanover, New Hampshire, and his medical degree at Upstate Medical Center, Syracuse, New York. He trained in internal medicine at the Peter Bent Brigham Hospital, Boston, Massachusetts, and the University of Alabama, Birmingham, and he completed his fellowship training in infectious diseases at the University of California, Los Angeles (UCLA). Before accepting his current position at The Johns Hopkins University, Dr. Bartlett served as a faculty member at UCLA and Tufts University School of Medicine in Boston, Massachusetts, and was associate chief of staff for research at the Boston VA Hospital.

    Figure. No caption a...

    Dr. Bartlett has worked in several areas of research, all related to his specialty in infectious diseases. His major research interests have included anaerobic infections, pathogenic mechanisms of Bacteroides fragilis, anaerobic pulmonary infections, and Clostridium difficile-associated colitis. Since moving to Johns Hopkins, his major interests have been HIV/AIDS, managed care of patients with HIV infection, and bioterrorism. Dr. Bartlett is a member of the Institute of Medicine, a master of the American College of Physicians, past president of the Infectious Diseases Society of America (IDSA), and a recipient of the Kass Award from the IDSA. In 2005, Dr. Bartlett was awarded the Alexander Fleming Award by the IDSA and the Finland Award from the National Foundation for Infectious Diseases (NFID). Dr. Bartlett has authored over 500 articles and reviews, more than 280 book chapters, and over 60 editions of 18 books. He participates as an editorial board member for numerous journals.

    Back to Top | Article Outline

    Previous Recipients of Lifetime Achievement Awards

    Lifetime Achievement Award for Scientific Contributions

    1999 George Klein, Karolinska Institute, Stockholm, Sweden

    2000 Maurice Hilleman, Merck Research Laboratories, Sumneytown, Pennsylvania

    2001 Hilary Koprowski, Thomas Jefferson University, Philadelphia, Pennsylvania

    2002 Alexander Rich, Massachusetts Institute of Technology, Cambridge, Massachusetts

    2003 Jan Svoboda, Institute of Molecular Genetics, Prague, Czech Republic

    2004 Paul Zamecnik, Massachusetts General Hospital, Boston, Massachusetts

    2005 Manfred Eigen, Max Planck Institute, Göttingen, Germany

    2006 Maxine Singer, National Institutes of Health, Bethesda, Maryland

    2008 Isaac P. Witz, Tel Aviv University, Tel Aviv, Israel

    2010 Dr. Rino Rappuoli, Novartis Vaccines in Sienna, Italy

    2011 Max Essex, Harvard AIDS Institute

    Lifetime Achievement Award for Public Service

    2004 Stewart Greenebaum, Greenebaum and Rose Associates, Inc., Baltimore, Maryland

    2006 Martin Delaney, Project Inform, San Francisco, California

    2008 John D. Evans, Evans Telecommunication Company and The Honorable Robert K. Gray, Gray and Company II, Miami, FL

    2010 Harry Huge, Esq.

    2011 Bernadine Healy, MD

    One-Time Lifetime Achievement Award for Excellence in Teaching

    2010 Michele LaPlaca, Bologna, Italy

    © 2013 Lippincott Williams & Wilkins, Inc.